Wife gives husband a thorough skin care routine
@ilymost submitted by /u/SinjiOnO to r/oddlysatisfying [link] [comments]
[Read more...](https://www.reddit.com/r/oddlysatisfying/comments/178wvfl/wifegiveshusbandathoroughskincareroutine/)
@ilymost submitted by /u/SinjiOnO to r/oddlysatisfying [link] [comments]
[Read more...](https://www.reddit.com/r/oddlysatisfying/comments/178wvfl/wifegiveshusbandathoroughskincareroutine/)
Reddit
Explore this post and more from the oddlysatisfying community
*I LOVE MY MOMMYYYY*
submitted by /u/Shoot2kill321 to r/wholesomememes [link] [comments]
[Read more...](https://www.reddit.com/r/wholesomememes/comments/178xkin/i_love_my_mommyyyy/)
submitted by /u/Shoot2kill321 to r/wholesomememes [link] [comments]
[Read more...](https://www.reddit.com/r/wholesomememes/comments/178xkin/i_love_my_mommyyyy/)
Reddit
Explore this post and more from the wholesomememes community
*Stacy speaks out about Johnie*
submitted by /u/Seashelz to r/LoveIsBlindOnNetflix [link] [comments]
[Read more...](https://www.reddit.com/r/LoveIsBlindOnNetflix/comments/178u5p9/stacy_speaks_out_about_johnie/)
submitted by /u/Seashelz to r/LoveIsBlindOnNetflix [link] [comments]
[Read more...](https://www.reddit.com/r/LoveIsBlindOnNetflix/comments/178u5p9/stacy_speaks_out_about_johnie/)
Reddit
Explore this post and more from the LoveIsBlindOnNetflix community
Stacy speaks out about Johnie
submitted by /u/Seashelz to r/LoveIsBlindOnNetflix link comments
Read more...
submitted by /u/Seashelz to r/LoveIsBlindOnNetflix link comments
Read more...
Reddit
Explore this post and more from the LoveIsBlindOnNetflix community
*AITA for refusing to use my sister's deadname for my baby?*
Hello, throwaway account because my husband knows my main one. I (34f) am currently 6 months pregnant. My husband (36m) and I have been married for three years and two prior. Ever since we started trying for kids (which was almost a year ago), he's been completely set on naming his first son after his favourite uncle, 'Lucas' (fake name.) When he first told me about this, I vetoed the name several times, however he kept bringing it up and saying I didn't have a choice here as I knew how important his uncle was to him. Two weeks ago, we found out we're having a boy.The issue is that 'Lucas' is my sister's (31mtf) old name. My sister is my best friend, and has been my rock throughout my entire life. I was the first person she ever came out to and I was there during her first therapy session (she asked me to be there as she was nervous and needed a hand to hold.) To say I respect and admire everything she's overcome is an understatement. When I told my sister about my husband's choice of name, she broke down in front of me, begging me to not let him use that name.For a bit of context, my sister hated her old name. She said it reminded her of how constricted her life was and how she was being forced to be someone she wasn't. Our parent's weren't accepting of her, so even after she changed her name, they would constantly call her 'Lucas.' She said if we used that name, she wouldn't be able to look at her nephew in the light she wants to. I've told my husband the exact reason why I didn't want to name our son 'Lucas,' and his response was that my sister can't keep us from using a name she isn't using anymore. Although I agree with half of that, I would hate for my sister to dislike my son because of his name. I've offered several other names that are similar but my husband says it's not the same. He's calling me selfish and an asshole for keeping this opportunity from him. AITA for not wanting to use my sister's old name for our son? Edit: Forgot reasoning. My husband thinks I'm the asshole for keeping him from naming our son after his uncle. However I don't want to upset my sister or remind her of any past trauma, as well as I don't want her to hate or dislike my son because of his name. I feel like this might make me the asshole because I know how important my husband's uncle was to him. Edit: My husband won't agree to using his uncle's name as the middle name. He says it isn't the same and wouldn't be 'honouring him correctly', whatever that means. Edit: Because some people have asked and others are suggesting alternative names for Lucas, the real name is Ivan. submitted by /u/squishmallow75693 to r/AmItheAsshole [link] [comments]
[Read more...](https://www.reddit.com/r/AmItheAsshole/comments/178v7fk/aita_for_refusing_to_use_my_sisters_deadname_for/)
Hello, throwaway account because my husband knows my main one. I (34f) am currently 6 months pregnant. My husband (36m) and I have been married for three years and two prior. Ever since we started trying for kids (which was almost a year ago), he's been completely set on naming his first son after his favourite uncle, 'Lucas' (fake name.) When he first told me about this, I vetoed the name several times, however he kept bringing it up and saying I didn't have a choice here as I knew how important his uncle was to him. Two weeks ago, we found out we're having a boy.The issue is that 'Lucas' is my sister's (31mtf) old name. My sister is my best friend, and has been my rock throughout my entire life. I was the first person she ever came out to and I was there during her first therapy session (she asked me to be there as she was nervous and needed a hand to hold.) To say I respect and admire everything she's overcome is an understatement. When I told my sister about my husband's choice of name, she broke down in front of me, begging me to not let him use that name.For a bit of context, my sister hated her old name. She said it reminded her of how constricted her life was and how she was being forced to be someone she wasn't. Our parent's weren't accepting of her, so even after she changed her name, they would constantly call her 'Lucas.' She said if we used that name, she wouldn't be able to look at her nephew in the light she wants to. I've told my husband the exact reason why I didn't want to name our son 'Lucas,' and his response was that my sister can't keep us from using a name she isn't using anymore. Although I agree with half of that, I would hate for my sister to dislike my son because of his name. I've offered several other names that are similar but my husband says it's not the same. He's calling me selfish and an asshole for keeping this opportunity from him. AITA for not wanting to use my sister's old name for our son? Edit: Forgot reasoning. My husband thinks I'm the asshole for keeping him from naming our son after his uncle. However I don't want to upset my sister or remind her of any past trauma, as well as I don't want her to hate or dislike my son because of his name. I feel like this might make me the asshole because I know how important my husband's uncle was to him. Edit: My husband won't agree to using his uncle's name as the middle name. He says it isn't the same and wouldn't be 'honouring him correctly', whatever that means. Edit: Because some people have asked and others are suggesting alternative names for Lucas, the real name is Ivan. submitted by /u/squishmallow75693 to r/AmItheAsshole [link] [comments]
[Read more...](https://www.reddit.com/r/AmItheAsshole/comments/178v7fk/aita_for_refusing_to_use_my_sisters_deadname_for/)
Reddit
Posted by squishmallow75693 - 2,624 votes and 1,630 comments
AITA for refusing to use my sister's deadname for my baby?
Hello, throwaway account because my husband knows my main one. I (34f) am currently 6 months pregnant. My husband (36m) and I have been married for three years and two prior. Ever since we started trying for kids (which was almost a year ago), he's been completely set on naming his first son after his favourite uncle, 'Lucas' (fake name.) When he first told me about this, I vetoed the name several times, however he kept bringing it up and saying I didn't have a choice here as I knew how important his uncle was to him. Two weeks ago, we found out we're having a boy.The issue is that 'Lucas' is my sister's (31mtf) old name. My sister is my best friend, and has been my rock throughout my entire life. I was the first person she ever came out to and I was there during her first therapy session (she asked me to be there as she was nervous and needed a hand to hold.) To say I respect and admire everything she's overcome is an understatement. When I told my sister about my husband's choice of name, she broke down in front of me, begging me to not let him use that name.For a bit of context, my sister hated her old name. She said it reminded her of how constricted her life was and how she was being forced to be someone she wasn't. Our parent's weren't accepting of her, so even after she changed her name, they would constantly call her 'Lucas.' She said if we used that name, she wouldn't be able to look at her nephew in the light she wants to. I've told my husband the exact reason why I didn't want to name our son 'Lucas,' and his response was that my sister can't keep us from using a name she isn't using anymore. Although I agree with half of that, I would hate for my sister to dislike my son because of his name. I've offered several other names that are similar but my husband says it's not the same. He's calling me selfish and an asshole for keeping this opportunity from him. AITA for not wanting to use my sister's old name for our son? Edit: Forgot reasoning. My husband thinks I'm the asshole for keeping him from naming our son after his uncle. However I don't want to upset my sister or remind her of any past trauma, as well as I don't want her to hate or dislike my son because of his name. I feel like this might make me the asshole because I know how important my husband's uncle was to him. Edit: My husband won't agree to using his uncle's name as the middle name. He says it isn't the same and wouldn't be 'honouring him correctly', whatever that means. Edit: Because some people have asked and others are suggesting alternative names for Lucas, the real name is Ivan. submitted by /u/squishmallow75693 to r/AmItheAsshole link comments
Read more...
Hello, throwaway account because my husband knows my main one. I (34f) am currently 6 months pregnant. My husband (36m) and I have been married for three years and two prior. Ever since we started trying for kids (which was almost a year ago), he's been completely set on naming his first son after his favourite uncle, 'Lucas' (fake name.) When he first told me about this, I vetoed the name several times, however he kept bringing it up and saying I didn't have a choice here as I knew how important his uncle was to him. Two weeks ago, we found out we're having a boy.The issue is that 'Lucas' is my sister's (31mtf) old name. My sister is my best friend, and has been my rock throughout my entire life. I was the first person she ever came out to and I was there during her first therapy session (she asked me to be there as she was nervous and needed a hand to hold.) To say I respect and admire everything she's overcome is an understatement. When I told my sister about my husband's choice of name, she broke down in front of me, begging me to not let him use that name.For a bit of context, my sister hated her old name. She said it reminded her of how constricted her life was and how she was being forced to be someone she wasn't. Our parent's weren't accepting of her, so even after she changed her name, they would constantly call her 'Lucas.' She said if we used that name, she wouldn't be able to look at her nephew in the light she wants to. I've told my husband the exact reason why I didn't want to name our son 'Lucas,' and his response was that my sister can't keep us from using a name she isn't using anymore. Although I agree with half of that, I would hate for my sister to dislike my son because of his name. I've offered several other names that are similar but my husband says it's not the same. He's calling me selfish and an asshole for keeping this opportunity from him. AITA for not wanting to use my sister's old name for our son? Edit: Forgot reasoning. My husband thinks I'm the asshole for keeping him from naming our son after his uncle. However I don't want to upset my sister or remind her of any past trauma, as well as I don't want her to hate or dislike my son because of his name. I feel like this might make me the asshole because I know how important my husband's uncle was to him. Edit: My husband won't agree to using his uncle's name as the middle name. He says it isn't the same and wouldn't be 'honouring him correctly', whatever that means. Edit: Because some people have asked and others are suggesting alternative names for Lucas, the real name is Ivan. submitted by /u/squishmallow75693 to r/AmItheAsshole link comments
Read more...
Reddit
Posted by squishmallow75693 - 2,624 votes and 1,630 comments
*Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions*
U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in overnight dealing as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.21% lower at 106.428 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.065%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents lower at $90.46 per barrel while WTI crude contracts for November, which are linked to U.S. gasoline prices, slipped 29 cents to $87.40 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a modest 6 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 100 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 1 point higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.06% lower in early Frankfurt trading while Britain's FTSE 100 edged 0.25% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stock-market-today-stocks-steady-as-markets-eye-middle-east-tensions)
U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in overnight dealing as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.21% lower at 106.428 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.065%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents lower at $90.46 per barrel while WTI crude contracts for November, which are linked to U.S. gasoline prices, slipped 29 cents to $87.40 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a modest 6 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 100 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 1 point higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.06% lower in early Frankfurt trading while Britain's FTSE 100 edged 0.25% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stock-market-today-stocks-steady-as-markets-eye-middle-east-tensions)
TheStreet
Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions
Investors are looking ahead cautiously to a busy week on Wall Street as tension in the middle east escalate and inflation concerns continue to clip sentiment.
Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions
U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in overnight dealing as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.21% lower at 106.428 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.065%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents lower at $90.46 per barrel while WTI crude contracts for November, which are linked to U.S. gasoline prices, slipped 29 cents to $87.40 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a modest 6 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 100 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 1 point higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.06% lower in early Frankfurt trading while Britain's FTSE 100 edged 0.25% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in overnight dealing as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.21% lower at 106.428 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.065%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents lower at $90.46 per barrel while WTI crude contracts for November, which are linked to U.S. gasoline prices, slipped 29 cents to $87.40 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a modest 6 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 100 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 1 point higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.06% lower in early Frankfurt trading while Britain's FTSE 100 edged 0.25% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions
Investors are looking ahead cautiously to a busy week on Wall Street as tension in the middle east escalate and inflation concerns continue to clip sentiment.
*Выгодно: женские ботинки ECCO со скидкой 30%*
Модель с меховой отделкой не даст ногам замёрзнуть зимой.
[Read more...](https://lifehacker.ru/zhenskie-botinki-ecco/)
Модель с меховой отделкой не даст ногам замёрзнуть зимой.
[Read more...](https://lifehacker.ru/zhenskie-botinki-ecco/)
*Tesla earnings, Jerome Powell speech, retail sales highlight key week on Wall Street*
Wall Street enters one of the most important weeks of the year Monday as investors hope that early signs of a robust third quarter earnings season will offset the surge in geopolitical risks and renewed rate and inflation concerns. Tesla (TSLA) - Get Free Report, Netflix (NFLX) - Get Free Report, AT&T (T) - Get Free Report and Johnson & Johnson (JNJ) - Get Free Report are just a few of the 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. JPMorgan CEO Jamie Dimon, however, cautioned investors that geopolitical risks in Europe, the Gulf region and China had combine to the point where "this may be the most dangerous time the world has seen in decades". That likely puts extra emphasis on earnings results over the next three weeks as investors look for reasons to extend bets on an end-of-year rally for the S&P 500 amid 'flight-to-safety' plays from global investors in a high interest rate environment that has pushed more than $1 trillion into money market funds this year, talking the total to a record $5.7 billion. Bank of America's Savita Subramanian notes that this third quarter earnings season is the first since the end of 2021 that hasn't seen downward revisions heading into the start of reporting, adding that "macro data and other indicators that we track generally point to a beat" in overall S&P 500 profits. "We see more green shoots than red flags," she said. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Earnings growth is expected to accelerate into the final months of the year, as well, with current forecasts pegging S&P 500 profits to expand by 10.6% from the same period last year to $482.5 billion. Tesla's third quarter earnings, slated for after the close of trading on Wednesday, will likely be the key release of the week and set the tone for risk markets heading into the end of the month. Analysts are estimating that its overall bottom line fell nearly 30% from a year earlier to 74 cents a share, even as revenue rose about 12% to around $24.16 billion. The difference is likely to be reflected in the group's closely tracked automotive margins, a key profit metric, which have been narrowing sharply over the past 12 months following Tesla's price-cut strategy. Beyond the earnings parade, investors will also navigate key reading of September retail sales Tuesday as markets bet that the resilient U.S jobs market, which added 336,000 new positions last month, translates into solid consumer spending. Economists expect headline sale to rise 0.3% from August, a slower pace of growth than recorded over the summer months, with a focus on whether the surge in oil and gasoline prices is pulling spending from discretionary categories such as restaurants and clothing stores. Beyond earnings and data, markets are also likely to key on a series of Fed speakers out in the field this week, including a stacked agenda Thursday that includes an address to the Economic Club of New York from Chairman Jerome Powell, which will come just hours after weekly jobless claims data which is again expected to underscore broader resilience, and inflation pressures, in the job market. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/tesla-earnings-powell-speech-retail-sales-top-key-week-on-wall-street)
Wall Street enters one of the most important weeks of the year Monday as investors hope that early signs of a robust third quarter earnings season will offset the surge in geopolitical risks and renewed rate and inflation concerns. Tesla (TSLA) - Get Free Report, Netflix (NFLX) - Get Free Report, AT&T (T) - Get Free Report and Johnson & Johnson (JNJ) - Get Free Report are just a few of the 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. JPMorgan CEO Jamie Dimon, however, cautioned investors that geopolitical risks in Europe, the Gulf region and China had combine to the point where "this may be the most dangerous time the world has seen in decades". That likely puts extra emphasis on earnings results over the next three weeks as investors look for reasons to extend bets on an end-of-year rally for the S&P 500 amid 'flight-to-safety' plays from global investors in a high interest rate environment that has pushed more than $1 trillion into money market funds this year, talking the total to a record $5.7 billion. Bank of America's Savita Subramanian notes that this third quarter earnings season is the first since the end of 2021 that hasn't seen downward revisions heading into the start of reporting, adding that "macro data and other indicators that we track generally point to a beat" in overall S&P 500 profits. "We see more green shoots than red flags," she said. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Earnings growth is expected to accelerate into the final months of the year, as well, with current forecasts pegging S&P 500 profits to expand by 10.6% from the same period last year to $482.5 billion. Tesla's third quarter earnings, slated for after the close of trading on Wednesday, will likely be the key release of the week and set the tone for risk markets heading into the end of the month. Analysts are estimating that its overall bottom line fell nearly 30% from a year earlier to 74 cents a share, even as revenue rose about 12% to around $24.16 billion. The difference is likely to be reflected in the group's closely tracked automotive margins, a key profit metric, which have been narrowing sharply over the past 12 months following Tesla's price-cut strategy. Beyond the earnings parade, investors will also navigate key reading of September retail sales Tuesday as markets bet that the resilient U.S jobs market, which added 336,000 new positions last month, translates into solid consumer spending. Economists expect headline sale to rise 0.3% from August, a slower pace of growth than recorded over the summer months, with a focus on whether the surge in oil and gasoline prices is pulling spending from discretionary categories such as restaurants and clothing stores. Beyond earnings and data, markets are also likely to key on a series of Fed speakers out in the field this week, including a stacked agenda Thursday that includes an address to the Economic Club of New York from Chairman Jerome Powell, which will come just hours after weekly jobless claims data which is again expected to underscore broader resilience, and inflation pressures, in the job market. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/tesla-earnings-powell-speech-retail-sales-top-key-week-on-wall-street)
TheStreet
Tesla earnings, Jerome Powell speech, retail sales highlight key week on Wall Street
Wall Street bulls face a crucial test this week as the third quarter earnings season shifts into full gear amid rising geopolitical tensions and renewed inflation risks.
Tesla earnings, Jerome Powell speech, retail sales highlight key week on Wall Street
Wall Street enters one of the most important weeks of the year Monday as investors hope that early signs of a robust third quarter earnings season will offset the surge in geopolitical risks and renewed rate and inflation concerns. Tesla (TSLA) - Get Free Report, Netflix (NFLX) - Get Free Report, AT&T (T) - Get Free Report and Johnson & Johnson (JNJ) - Get Free Report are just a few of the 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. JPMorgan CEO Jamie Dimon, however, cautioned investors that geopolitical risks in Europe, the Gulf region and China had combine to the point where "this may be the most dangerous time the world has seen in decades". That likely puts extra emphasis on earnings results over the next three weeks as investors look for reasons to extend bets on an end-of-year rally for the S&P 500 amid 'flight-to-safety' plays from global investors in a high interest rate environment that has pushed more than $1 trillion into money market funds this year, talking the total to a record $5.7 billion. Bank of America's Savita Subramanian notes that this third quarter earnings season is the first since the end of 2021 that hasn't seen downward revisions heading into the start of reporting, adding that "macro data and other indicators that we track generally point to a beat" in overall S&P 500 profits. "We see more green shoots than red flags," she said. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Earnings growth is expected to accelerate into the final months of the year, as well, with current forecasts pegging S&P 500 profits to expand by 10.6% from the same period last year to $482.5 billion. Tesla's third quarter earnings, slated for after the close of trading on Wednesday, will likely be the key release of the week and set the tone for risk markets heading into the end of the month. Analysts are estimating that its overall bottom line fell nearly 30% from a year earlier to 74 cents a share, even as revenue rose about 12% to around $24.16 billion. The difference is likely to be reflected in the group's closely tracked automotive margins, a key profit metric, which have been narrowing sharply over the past 12 months following Tesla's price-cut strategy. Beyond the earnings parade, investors will also navigate key reading of September retail sales Tuesday as markets bet that the resilient U.S jobs market, which added 336,000 new positions last month, translates into solid consumer spending. Economists expect headline sale to rise 0.3% from August, a slower pace of growth than recorded over the summer months, with a focus on whether the surge in oil and gasoline prices is pulling spending from discretionary categories such as restaurants and clothing stores. Beyond earnings and data, markets are also likely to key on a series of Fed speakers out in the field this week, including a stacked agenda Thursday that includes an address to the Economic Club of New York from Chairman Jerome Powell, which will come just hours after weekly jobless claims data which is again expected to underscore broader resilience, and inflation pressures, in the job market. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
Wall Street enters one of the most important weeks of the year Monday as investors hope that early signs of a robust third quarter earnings season will offset the surge in geopolitical risks and renewed rate and inflation concerns. Tesla (TSLA) - Get Free Report, Netflix (NFLX) - Get Free Report, AT&T (T) - Get Free Report and Johnson & Johnson (JNJ) - Get Free Report are just a few of the 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. JPMorgan CEO Jamie Dimon, however, cautioned investors that geopolitical risks in Europe, the Gulf region and China had combine to the point where "this may be the most dangerous time the world has seen in decades". That likely puts extra emphasis on earnings results over the next three weeks as investors look for reasons to extend bets on an end-of-year rally for the S&P 500 amid 'flight-to-safety' plays from global investors in a high interest rate environment that has pushed more than $1 trillion into money market funds this year, talking the total to a record $5.7 billion. Bank of America's Savita Subramanian notes that this third quarter earnings season is the first since the end of 2021 that hasn't seen downward revisions heading into the start of reporting, adding that "macro data and other indicators that we track generally point to a beat" in overall S&P 500 profits. "We see more green shoots than red flags," she said. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Earnings growth is expected to accelerate into the final months of the year, as well, with current forecasts pegging S&P 500 profits to expand by 10.6% from the same period last year to $482.5 billion. Tesla's third quarter earnings, slated for after the close of trading on Wednesday, will likely be the key release of the week and set the tone for risk markets heading into the end of the month. Analysts are estimating that its overall bottom line fell nearly 30% from a year earlier to 74 cents a share, even as revenue rose about 12% to around $24.16 billion. The difference is likely to be reflected in the group's closely tracked automotive margins, a key profit metric, which have been narrowing sharply over the past 12 months following Tesla's price-cut strategy. Beyond the earnings parade, investors will also navigate key reading of September retail sales Tuesday as markets bet that the resilient U.S jobs market, which added 336,000 new positions last month, translates into solid consumer spending. Economists expect headline sale to rise 0.3% from August, a slower pace of growth than recorded over the summer months, with a focus on whether the surge in oil and gasoline prices is pulling spending from discretionary categories such as restaurants and clothing stores. Beyond earnings and data, markets are also likely to key on a series of Fed speakers out in the field this week, including a stacked agenda Thursday that includes an address to the Economic Club of New York from Chairman Jerome Powell, which will come just hours after weekly jobless claims data which is again expected to underscore broader resilience, and inflation pressures, in the job market. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Tesla earnings, Jerome Powell speech, retail sales highlight key week on Wall Street
Wall Street bulls face a crucial test this week as the third quarter earnings season shifts into full gear amid rising geopolitical tensions and renewed inflation risks.
*Банк России показал дизайн обновлённых купюр номиналом 1000 и 5000 рублей*
На них изображены достопримечательности Нижнего Новгорода, Казани, Уфы, Екатеринбурга, Челябинска и Салехарда.
[Read more...](https://lifehacker.ru/bank-rossii-dizajn-kupyur-1000-i-5000-rublej/)
На них изображены достопримечательности Нижнего Новгорода, Казани, Уфы, Екатеринбурга, Челябинска и Салехарда.
[Read more...](https://lifehacker.ru/bank-rossii-dizajn-kupyur-1000-i-5000-rublej/)
*Taylor Swift 'Eras Tour' Film smashes box office records but can't lift AMC*
AMC Entertainment (AMC) - Get Free Report shares edged lower in pre-market trading despite data suggesting that Taylor Swift: The Eras Tour movie generated nearly $100 million in box office receipts over the weekend, making it the highest-grossing concert film on record. The film, which chronicles the stadium tour as well as highlights from the seventeen-year career of one of the world's biggest and most lucrative entertainers, likely drew between $95 million and $105 million in weekend revenues in the U.S. and Canada, based on data from Comscore and Boxoffice Pro, with another $30 million-plus from international markets. The overall tally for the Eras Tour film, which was shot from performances at Los Angeles' SoFi stadium, dwarfs the previous concert film record, attributed to Justin Bieber's 2011 release 'Never Say Never', which drew around $29.5 million in its opening weekend and $99 million from hits entire months-long run. "With more reviews out and millions watching the movie, people are raving about Taylor Swift The Eras Tour," said AMC CEO Adam Aron in a post on the social media website X. "We won’t know exactly until Sunday, but likely to be one of the biggest grossing movies of all time released during the month of October." AMC Entertainment shares were marked 0.63% lower in pre-market trading to indicate an opening bell price of $9.44 each. AMC reported a surprise second quarter profit of a penny a share in late August, with revenue rising 15.6% to $1.35 billion. It said the current quarter was off to an "explosive" start thanks to the success of summer blockbusters "Barbie" and "Oppenheimer," which combined for the best box office opening weekend in four years in late July. 'Barbie,' the Warner Bros. Discover (WBD) - Get Free Report film about the eponymous Mattel (MAT) - Get Free Report-made doll staring Margot Robbie and Ryan Gosling, has taken in $1.35 billion in global office receipts since its late July debut, according to Comscore data, surpassing 'Super Mario Bros. Movie' as the biggest hit of the year. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/taylor-swift-eras-tour-film-smashes-box-office-but-cant-lift-amc)
AMC Entertainment (AMC) - Get Free Report shares edged lower in pre-market trading despite data suggesting that Taylor Swift: The Eras Tour movie generated nearly $100 million in box office receipts over the weekend, making it the highest-grossing concert film on record. The film, which chronicles the stadium tour as well as highlights from the seventeen-year career of one of the world's biggest and most lucrative entertainers, likely drew between $95 million and $105 million in weekend revenues in the U.S. and Canada, based on data from Comscore and Boxoffice Pro, with another $30 million-plus from international markets. The overall tally for the Eras Tour film, which was shot from performances at Los Angeles' SoFi stadium, dwarfs the previous concert film record, attributed to Justin Bieber's 2011 release 'Never Say Never', which drew around $29.5 million in its opening weekend and $99 million from hits entire months-long run. "With more reviews out and millions watching the movie, people are raving about Taylor Swift The Eras Tour," said AMC CEO Adam Aron in a post on the social media website X. "We won’t know exactly until Sunday, but likely to be one of the biggest grossing movies of all time released during the month of October." AMC Entertainment shares were marked 0.63% lower in pre-market trading to indicate an opening bell price of $9.44 each. AMC reported a surprise second quarter profit of a penny a share in late August, with revenue rising 15.6% to $1.35 billion. It said the current quarter was off to an "explosive" start thanks to the success of summer blockbusters "Barbie" and "Oppenheimer," which combined for the best box office opening weekend in four years in late July. 'Barbie,' the Warner Bros. Discover (WBD) - Get Free Report film about the eponymous Mattel (MAT) - Get Free Report-made doll staring Margot Robbie and Ryan Gosling, has taken in $1.35 billion in global office receipts since its late July debut, according to Comscore data, surpassing 'Super Mario Bros. Movie' as the biggest hit of the year. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/taylor-swift-eras-tour-film-smashes-box-office-but-cant-lift-amc)
TheStreet
Taylor Swift 'Eras Tour' Film smashes box office records but can't lift AMC
Mega star Taylor Swift's Eras Tour movie likely drew $120 million in box office receipts this weekend, the most-ever for a concert film and a record for any October movie release.
Taylor Swift 'Eras Tour' Film smashes box office records but can't lift AMC
AMC Entertainment (AMC) - Get Free Report shares edged lower in pre-market trading despite data suggesting that Taylor Swift: The Eras Tour movie generated nearly $100 million in box office receipts over the weekend, making it the highest-grossing concert film on record. The film, which chronicles the stadium tour as well as highlights from the seventeen-year career of one of the world's biggest and most lucrative entertainers, likely drew between $95 million and $105 million in weekend revenues in the U.S. and Canada, based on data from Comscore and Boxoffice Pro, with another $30 million-plus from international markets. The overall tally for the Eras Tour film, which was shot from performances at Los Angeles' SoFi stadium, dwarfs the previous concert film record, attributed to Justin Bieber's 2011 release 'Never Say Never', which drew around $29.5 million in its opening weekend and $99 million from hits entire months-long run. "With more reviews out and millions watching the movie, people are raving about Taylor Swift The Eras Tour," said AMC CEO Adam Aron in a post on the social media website X. "We won’t know exactly until Sunday, but likely to be one of the biggest grossing movies of all time released during the month of October." AMC Entertainment shares were marked 0.63% lower in pre-market trading to indicate an opening bell price of $9.44 each. AMC reported a surprise second quarter profit of a penny a share in late August, with revenue rising 15.6% to $1.35 billion. It said the current quarter was off to an "explosive" start thanks to the success of summer blockbusters "Barbie" and "Oppenheimer," which combined for the best box office opening weekend in four years in late July. 'Barbie,' the Warner Bros. Discover (WBD) - Get Free Report film about the eponymous Mattel (MAT) - Get Free Report-made doll staring Margot Robbie and Ryan Gosling, has taken in $1.35 billion in global office receipts since its late July debut, according to Comscore data, surpassing 'Super Mario Bros. Movie' as the biggest hit of the year. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
AMC Entertainment (AMC) - Get Free Report shares edged lower in pre-market trading despite data suggesting that Taylor Swift: The Eras Tour movie generated nearly $100 million in box office receipts over the weekend, making it the highest-grossing concert film on record. The film, which chronicles the stadium tour as well as highlights from the seventeen-year career of one of the world's biggest and most lucrative entertainers, likely drew between $95 million and $105 million in weekend revenues in the U.S. and Canada, based on data from Comscore and Boxoffice Pro, with another $30 million-plus from international markets. The overall tally for the Eras Tour film, which was shot from performances at Los Angeles' SoFi stadium, dwarfs the previous concert film record, attributed to Justin Bieber's 2011 release 'Never Say Never', which drew around $29.5 million in its opening weekend and $99 million from hits entire months-long run. "With more reviews out and millions watching the movie, people are raving about Taylor Swift The Eras Tour," said AMC CEO Adam Aron in a post on the social media website X. "We won’t know exactly until Sunday, but likely to be one of the biggest grossing movies of all time released during the month of October." AMC Entertainment shares were marked 0.63% lower in pre-market trading to indicate an opening bell price of $9.44 each. AMC reported a surprise second quarter profit of a penny a share in late August, with revenue rising 15.6% to $1.35 billion. It said the current quarter was off to an "explosive" start thanks to the success of summer blockbusters "Barbie" and "Oppenheimer," which combined for the best box office opening weekend in four years in late July. 'Barbie,' the Warner Bros. Discover (WBD) - Get Free Report film about the eponymous Mattel (MAT) - Get Free Report-made doll staring Margot Robbie and Ryan Gosling, has taken in $1.35 billion in global office receipts since its late July debut, according to Comscore data, surpassing 'Super Mario Bros. Movie' as the biggest hit of the year. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Taylor Swift 'Eras Tour' Film smashes box office records but can't lift AMC
Mega star Taylor Swift's Eras Tour movie likely drew $120 million in box office receipts this weekend, the most-ever for a concert film and a record for any October movie release.
*Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales*
Pfizer (PFE) - Get Free Report shares slumped lower in pre-market trading after the drugmaker slashed its full-year sales and profits forecasts, while unveiling steep job cuts, linked to slowing demand for its Covid vaccines and treatments. In a late Friday update that precedes a group conference call with analysts later today, Pfizer said full-year group revenues would likely come in between $58 billion and $61 billion, down from its early August forecast of between $67 billion and $70 billion, amid slumping sales of its Comirnaty covid vaccine and its Paxlovid antiviral treatment. In response, Pfizer said it would write-off around $4.6 billion in Paxlovid inventories, while taking a further $5.5 billion non-cash charge against its third quarter earnings. It also unveiled plans for a $3.5 billion cost-cutting program, spread over two years, that will include a significant number of job cuts. Pfizer also said adjusted earnings for the full-year will likely be within a range of $1.45 to $1.65 per share, well south of its August forecast of between $3.25 to $3.45 per share. "Pfizer’s non-COVID product portfolio remains strong, and we continue to expect these products to achieve year-over-year operational revenue growth in the range of 6% to 8% in 2023," said CEO Albert Bourla. "We remain proud that our scientific breakthroughs played a significant role in getting the global health crisis under control," he added. "We continue to expect our COVID-related revenues to contribute to our business in future periods, helping us to further invest in activities that drive Pfizer’s long-term growth potential.” Pfizer shares were marked 3.3% lower in pre-market trading to indicate an opening bell price of $31.06 per share. Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/pfizer-slumps-after-slashing-profit-forecast-on-tumbling-covid-sales)
Pfizer (PFE) - Get Free Report shares slumped lower in pre-market trading after the drugmaker slashed its full-year sales and profits forecasts, while unveiling steep job cuts, linked to slowing demand for its Covid vaccines and treatments. In a late Friday update that precedes a group conference call with analysts later today, Pfizer said full-year group revenues would likely come in between $58 billion and $61 billion, down from its early August forecast of between $67 billion and $70 billion, amid slumping sales of its Comirnaty covid vaccine and its Paxlovid antiviral treatment. In response, Pfizer said it would write-off around $4.6 billion in Paxlovid inventories, while taking a further $5.5 billion non-cash charge against its third quarter earnings. It also unveiled plans for a $3.5 billion cost-cutting program, spread over two years, that will include a significant number of job cuts. Pfizer also said adjusted earnings for the full-year will likely be within a range of $1.45 to $1.65 per share, well south of its August forecast of between $3.25 to $3.45 per share. "Pfizer’s non-COVID product portfolio remains strong, and we continue to expect these products to achieve year-over-year operational revenue growth in the range of 6% to 8% in 2023," said CEO Albert Bourla. "We remain proud that our scientific breakthroughs played a significant role in getting the global health crisis under control," he added. "We continue to expect our COVID-related revenues to contribute to our business in future periods, helping us to further invest in activities that drive Pfizer’s long-term growth potential.” Pfizer shares were marked 3.3% lower in pre-market trading to indicate an opening bell price of $31.06 per share. Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/pfizer-slumps-after-slashing-profit-forecast-on-tumbling-covid-sales)
TheStreet
Pfizer jumps as investors look past Covid vaccine forecast to possible price hikes
Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.
Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales
Pfizer (PFE) - Get Free Report shares slumped lower in pre-market trading after the drugmaker slashed its full-year sales and profits forecasts, while unveiling steep job cuts, linked to slowing demand for its Covid vaccines and treatments. In a late Friday update that precedes a group conference call with analysts later today, Pfizer said full-year group revenues would likely come in between $58 billion and $61 billion, down from its early August forecast of between $67 billion and $70 billion, amid slumping sales of its Comirnaty covid vaccine and its Paxlovid antiviral treatment. In response, Pfizer said it would write-off around $4.6 billion in Paxlovid inventories, while taking a further $5.5 billion non-cash charge against its third quarter earnings. It also unveiled plans for a $3.5 billion cost-cutting program, spread over two years, that will include a significant number of job cuts. Pfizer also said adjusted earnings for the full-year will likely be within a range of $1.45 to $1.65 per share, well south of its August forecast of between $3.25 to $3.45 per share. "Pfizer’s non-COVID product portfolio remains strong, and we continue to expect these products to achieve year-over-year operational revenue growth in the range of 6% to 8% in 2023," said CEO Albert Bourla. "We remain proud that our scientific breakthroughs played a significant role in getting the global health crisis under control," he added. "We continue to expect our COVID-related revenues to contribute to our business in future periods, helping us to further invest in activities that drive Pfizer’s long-term growth potential.” Pfizer shares were marked 3.3% lower in pre-market trading to indicate an opening bell price of $31.06 per share. Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...
Pfizer (PFE) - Get Free Report shares slumped lower in pre-market trading after the drugmaker slashed its full-year sales and profits forecasts, while unveiling steep job cuts, linked to slowing demand for its Covid vaccines and treatments. In a late Friday update that precedes a group conference call with analysts later today, Pfizer said full-year group revenues would likely come in between $58 billion and $61 billion, down from its early August forecast of between $67 billion and $70 billion, amid slumping sales of its Comirnaty covid vaccine and its Paxlovid antiviral treatment. In response, Pfizer said it would write-off around $4.6 billion in Paxlovid inventories, while taking a further $5.5 billion non-cash charge against its third quarter earnings. It also unveiled plans for a $3.5 billion cost-cutting program, spread over two years, that will include a significant number of job cuts. Pfizer also said adjusted earnings for the full-year will likely be within a range of $1.45 to $1.65 per share, well south of its August forecast of between $3.25 to $3.45 per share. "Pfizer’s non-COVID product portfolio remains strong, and we continue to expect these products to achieve year-over-year operational revenue growth in the range of 6% to 8% in 2023," said CEO Albert Bourla. "We remain proud that our scientific breakthroughs played a significant role in getting the global health crisis under control," he added. "We continue to expect our COVID-related revenues to contribute to our business in future periods, helping us to further invest in activities that drive Pfizer’s long-term growth potential.” Pfizer shares were marked 3.3% lower in pre-market trading to indicate an opening bell price of $31.06 per share. Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...
TheStreet
Pfizer jumps as investors look past Covid vaccine forecast to possible price hikes
Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.
*Композитный*
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3569774.html)
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3569774.html)
Forma-Odezhda
Композитный подносок
Узнайте о Композитный подносок в энциклопедии магазина Форма одежды.
Композитный
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/edc1Oom Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
Композитный подносок
Узнайте о Композитный подносок в энциклопедии магазина Форма одежды.
*Несущая Платформа*
via forma full 5 https://ift.tt/bdTuRVl Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3570605.html)
via forma full 5 https://ift.tt/bdTuRVl Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3570605.html)
Forma-Odezhda
Несущая платформа MOLLE (PALS) и её варианты
Узнайте о Несущая платформа MOLLE (PALS) и её варианты в энциклопедии магазина Форма одежды.